doc. MUDr. Daniela Žáčková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2838, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 218
2024
-
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
American Journal of Hematology, year: 2024, DOI
-
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes
Blood advances, year: 2024, DOI
-
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib
Leukemia, year: 2024, DOI
-
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
Leukemia, year: 2024, DOI
2023
-
Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response
Year: 2023, type: Conference abstract
-
Asciminib - nová možnost v léčbě CML
Farmakoterapie, year: 2023, volume: 19, edition: 3
-
Asciminib v léčbě pacienta se závažnou intolerancí dostupných inhibitorů tyrosinkinázy
Farmakoterapie, year: 2023, volume: 2023, edition: 6
-
Bosutinib v terapii chronické myeloidní leukemie v každodenní praxi – analýzy z databáze INFINITY
Year: 2023, type: Conference abstract
-
Cévní nežádoucí účinky u pacientů s chronickou myeloidní leukemií při terapii inhibitory tyrozinkináz v každodenní klinické praxi – analýza z databáze INFINITY
Transfuze a Hematologie Dnes, year: 2023, volume: 29, edition: 1, DOI
-
Cílená léčba chronické myeloidní leukemie
Profi Medicína, year: 2023, volume: 2023, edition: 2